Recent News

Share
520 News Items found
Pictured: Eric Holland, Franziska Michor, and Desert Horse-Grant
New Center Uses Mathematical Models to Understand Cancer
In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States.
Timothy A. Chan
Researchers Link Gene that Causes Parkinson's Disease to Cancer
A multidisciplinary team of Memorial Sloan Kettering investigators has shown for the first time that the gene that causes the inherited form of Parkinson's disease also plays a role in many types of cancer, including colon and lung cancers and glioblastoma, the most common form of brain cancer.
Samuel Singer
Samuel Singer Appointed Service Chief
Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery.
Postdoctoral researchers discuss a poster presentation
Work of Postdoctoral Researchers Spotlighted at Third Annual Symposium
Each year since 2007, Memorial Sloan Kettering's postdoctoral researchers have had the opportunity to showcase their research accomplishments at the annual Postdoctoral Research Symposium.
Joan Massagué
Self-Seeding of Cancer Cells May Play a Critical Role in Tumor Progression
Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers at Memorial Sloan Kettering Cancer Center shows that circulating tumor cells - cancer cells that break away from a primary tumor and disseminate to other areas of the body - can also return to and grow in their tumor of origin, a newly discovered process called "self-seeding."
Alexandra Joyner
Alexandra Joyner Elected to the Institute of Medicine
Alexandra L. Joyner have been elected members of the Institute of Medicine.
Simon Powell
An Interview With Simon Powell
Dr. Powell joined Memorial Sloan Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan Kettering Institute's Molecular Biology Program.
Francis M. Sirotnak
FDA Approves Lymphoma Drug Developed at Memorial Sloan Kettering
Patients with a rare but aggressive form of cancer now have access to a drug that has proven effective after the disease becomes resistant to standard treatments.
James Allison
Researchers Design More Effective Cancer Vaccine
Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors.
Pictured: Kenneth J. Marians
Gerstner Sloan Kettering Receives Grant from Howard Hughes Medical Institute Initiative
The Howard Hughes Medical Institute (HHMI) announced that Memorial Sloan Kettering Cancer Center's Gerstner Sloan Kettering Graduate School of Biomedical Sciences is one of 23 research institutions to receive a grant as part of HHMI's Med into Grad Initiative.